Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 06 2018
revised: 16 09 2018
accepted: 16 10 2018
entrez: 27 1 2019
pubmed: 27 1 2019
medline: 6 6 2020
Statut: ppublish

Résumé

The rise in contraceptive use has largely been driven by short-acting methods of contraception, despite the high effectiveness of long-acting reversible contraceptives. Several countries in Latin America and the Caribbean have made important progress increasing the use of modern contraceptives, but important inequalities remain. We assessed the prevalence and demand for modern contraceptive use in Latin America and the Caribbean with data from national health surveys. Our data sources included demographic and health surveys, multiple indicator cluster surveys, and reproductive health surveys carried out since 2004 in 23 countries of Latin America and the Caribbean. Analyses were based on sexually active women aged 15-49 years irrespective of marital status, except in Argentina and Brazil, where analyses were restricted to women who were married or in a union. We calculated contraceptive prevalence and demand for family planning satisfied. Contraceptive prevalence was defined as the percentage of sexually active women aged 15-49 years who (or whose partners) were using a contraceptive method at the time of the survey. Demand for family planning satisfied was defined as the proportion of women in need of contraception who were using a contraceptive method at the time of the survey. We separated survey data for modern contraceptive use by type of contraception used (long-acting, short-acting, or permanent). We also stratified survey data by wealth, area of residence, education, ethnicity, age, and a combination of wealth and area of residence. Wealth-related absolute and relative inequalities were estimated both for contraceptive prevalence and demand for family planning satisfied. We report on surveys from 23 countries in Latin America and the Caribbean, analysing a sample of 212 573 women. The lowest modern contraceptive prevalence was observed in Haiti (31·3%) and Bolivia (34·6%); inequalities were wide in Bolivia, but almost non-existent in Haiti. Brazil, Colombia, Costa Rica, Cuba, and Paraguay had over 70% of modern contraceptive prevalence with low absolute inequalities. Use of long-acting reversible contraceptives was below 10% in 17 of the 23 countries. Only Cuba, Colombia, Mexico, Ecuador, Paraguay, and Trinidad and Tobago had more than 10% of women adopting long-acting contraceptive methods. Mexico was the only country in which long-acting contraceptive methods were more frequently used than short-acting methods. Young women aged 15-17 years, indigenous women, those in lower wealth quintiles, those living in rural areas, and those without education showed particularly low use of long-acting reversible contraceptives. Long-acting reversible contraceptives are seldom used in Latin America and the Caribbean. Because of their high effectiveness, convenience, and ease of continuation, availability of long-acting reversible contraceptives should be expanded and their use promoted, including among young and nulliparous women. In addition to suitable family planning services, information and counselling should be provided to women on a personal basis. Wellcome Trust, Pan American Health Organization.

Sections du résumé

BACKGROUND
The rise in contraceptive use has largely been driven by short-acting methods of contraception, despite the high effectiveness of long-acting reversible contraceptives. Several countries in Latin America and the Caribbean have made important progress increasing the use of modern contraceptives, but important inequalities remain. We assessed the prevalence and demand for modern contraceptive use in Latin America and the Caribbean with data from national health surveys.
METHODS
Our data sources included demographic and health surveys, multiple indicator cluster surveys, and reproductive health surveys carried out since 2004 in 23 countries of Latin America and the Caribbean. Analyses were based on sexually active women aged 15-49 years irrespective of marital status, except in Argentina and Brazil, where analyses were restricted to women who were married or in a union. We calculated contraceptive prevalence and demand for family planning satisfied. Contraceptive prevalence was defined as the percentage of sexually active women aged 15-49 years who (or whose partners) were using a contraceptive method at the time of the survey. Demand for family planning satisfied was defined as the proportion of women in need of contraception who were using a contraceptive method at the time of the survey. We separated survey data for modern contraceptive use by type of contraception used (long-acting, short-acting, or permanent). We also stratified survey data by wealth, area of residence, education, ethnicity, age, and a combination of wealth and area of residence. Wealth-related absolute and relative inequalities were estimated both for contraceptive prevalence and demand for family planning satisfied.
FINDINGS
We report on surveys from 23 countries in Latin America and the Caribbean, analysing a sample of 212 573 women. The lowest modern contraceptive prevalence was observed in Haiti (31·3%) and Bolivia (34·6%); inequalities were wide in Bolivia, but almost non-existent in Haiti. Brazil, Colombia, Costa Rica, Cuba, and Paraguay had over 70% of modern contraceptive prevalence with low absolute inequalities. Use of long-acting reversible contraceptives was below 10% in 17 of the 23 countries. Only Cuba, Colombia, Mexico, Ecuador, Paraguay, and Trinidad and Tobago had more than 10% of women adopting long-acting contraceptive methods. Mexico was the only country in which long-acting contraceptive methods were more frequently used than short-acting methods. Young women aged 15-17 years, indigenous women, those in lower wealth quintiles, those living in rural areas, and those without education showed particularly low use of long-acting reversible contraceptives.
INTERPRETATION
Long-acting reversible contraceptives are seldom used in Latin America and the Caribbean. Because of their high effectiveness, convenience, and ease of continuation, availability of long-acting reversible contraceptives should be expanded and their use promoted, including among young and nulliparous women. In addition to suitable family planning services, information and counselling should be provided to women on a personal basis.
FUNDING
Wellcome Trust, Pan American Health Organization.

Identifiants

pubmed: 30683240
pii: S2214-109X(18)30481-9
doi: 10.1016/S2214-109X(18)30481-9
pmc: PMC6367565
pii:
doi:

Substances chimiques

Contraceptive Agents 0
Contraceptives, Oral 0
Drug Implants 0
Spermatocidal Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e227-e235

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

Rev Panam Salud Publica. 2015 Jul;38(1):9-16
pubmed: 26506316
Int J Epidemiol. 2012 Dec;41(6):1595-601
pubmed: 23211414
Rev Saude Publica. 2017 Jun 01;51(suppl 1):3s
pubmed: 28591351
Contraception. 2015 Nov;92(5):420-1
pubmed: 26276245
Reprod Health. 2017 Jul 14;14(1):83
pubmed: 28705166
Contraception. 2016 Oct;94(4):289-94
pubmed: 27287693
Contraception. 2016 Jul;94(1):11-7
pubmed: 27018154
Glob Health Sci Pract. 2016 Mar 25;4(1):43-54
pubmed: 27016543
Lancet Glob Health. 2018 Aug;6(8):e902-e913
pubmed: 30012271
Int J Equity Health. 2003 Oct 9;2(1):8
pubmed: 14609435
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108
Glob Health Sci Pract. 2017 Sep 28;5(3):382-398
pubmed: 28765156
Int J Gynaecol Obstet. 2015 Aug;130 Suppl 3:E3-7
pubmed: 26001703
Demography. 2001 Feb;38(1):115-32
pubmed: 11227840
Int J Gynaecol Obstet. 2015 Oct;131 Suppl 1:S60-3
pubmed: 26433510
Drugs. 2011 May 28;71(8):969-80
pubmed: 21668037
PLoS Med. 2013;10(5):e1001390
pubmed: 23667332
Glob Health Action. 2015 Nov 09;8:29735
pubmed: 26562141
Contracept Reprod Med. 2016 Feb 23;1:4
pubmed: 29201394
Contraception. 2013 Feb;87(2):170-5
pubmed: 23153895
Hum Reprod Open. 2018 Jan 23;2018(1):hox030
pubmed: 30895242

Auteurs

Rodolfo Gomez Ponce de Leon (RG)

Latin American Center for Perinatology/Women's Health and Reproductive Health of the Pan American Health Organization (CLAP/WR-PAHO/WHO), Montevideo, Uruguay.

Fernanda Ewerling (F)

International Center for Equity in Health (ICEH), Federal University of Pelotas, Pelotas, RS, Brazil; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil.

Suzanne Jacob Serruya (SJ)

Latin American Center for Perinatology/Women's Health and Reproductive Health of the Pan American Health Organization (CLAP/WR-PAHO/WHO), Montevideo, Uruguay.

Mariangela F Silveira (MF)

Latin American Center for Perinatology/Women's Health and Reproductive Health of the Pan American Health Organization (CLAP/WR-PAHO/WHO), Montevideo, Uruguay; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil.

Antonio Sanhueza (A)

Pan American Health Organization (PAHO), Washington, DC, USA.

Ali Moazzam (A)

Department of Reproductive Health and Research (RHR), World Health Organization, Geneva, Switzerland.

Francisco Becerra-Posada (F)

Pan American Health Organization (PAHO), Washington, DC, USA.

Carolina V N Coll (CVN)

International Center for Equity in Health (ICEH), Federal University of Pelotas, Pelotas, RS, Brazil; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil.

Franciele Hellwig (F)

International Center for Equity in Health (ICEH), Federal University of Pelotas, Pelotas, RS, Brazil; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil.

Cesar G Victora (CG)

International Center for Equity in Health (ICEH), Federal University of Pelotas, Pelotas, RS, Brazil; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil.

Aluisio J D Barros (AJD)

International Center for Equity in Health (ICEH), Federal University of Pelotas, Pelotas, RS, Brazil; Faculty of Medicine, Federal University of Pelotas, Pelotas, RS, Brazil. Electronic address: abarros@equidade.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH